Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity (Q81230515)
Jump to navigation
Jump to search
scientific article published on 01 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity |
scientific article published on 01 September 2007 |
Statements
Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity (English)
Nawroth PP
Bierhaus A
Rudofsky G Jr
Reismann P
Grafe IA
Konrade I
Djuric Z
Tafel J
Buchbinder S
Zorn M
Hamann A
1 September 2007